Barclays
TELA icon

Barclays’s TELA Bio TELA Stock Holding History

Barclays’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156 Buy
+208
New +$170 ﹤0.01% 5143
2025
Q2 		– Sell
-4
Closed -$5 – 5534
2025
Q1 		$5 Buy
+4
New +$10 ﹤0.01% 5196
2024
Q3 		– Sell
-143
Closed -$672 – 5476
2024
Q2 		$672 Sell
143
-11,294
-99% -$59.5K ﹤0.01% 4701
2024
Q1 		$64.8K Sell
11,437
-10,833
-49% -$71.4K ﹤0.01% 4560
2023
Q4 		$147K Buy
22,270
+19,341
+660% +$112K ﹤0.01% 4533
2023
Q3 		$23.4K Sell
2,929
-246
-8% -$2.29K ﹤0.01% 4139
2023
Q2 		$32.2K Buy
+3,175
New +$32.5K ﹤0.01% 4014

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's TELA Position: Q2 2026 in Review

Barclays opened a new position in TELA Bio (TELA) in Q2 2026: 208 shares worth $156. The stake represents ﹤0.01% of the portfolio and ranks #5143 among its holdings. This is a return to the name: Barclays previously reported a position in TELA as recently as Q1 2025.

Barclays first reported a position in TELA in Q2 2023 and has held it in 7 quarters since. The position peaked at $147K in Q4 2023. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Barclays held 208 shares of TELA Bio worth $156 as of Q2 2026.
  • TELA Bio was a new Barclays position in Q2 2026.
  • TELA Bio made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5143 holding.
  • Barclays first reported a position in TELA Bio in Q2 2023 and has held it in 7 quarters since.
  • Barclays's TELA Bio position peaked at $147K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.